0001140361-23-026719.txt : 20230525
0001140361-23-026719.hdr.sgml : 20230525
20230525182200
ACCESSION NUMBER: 0001140361-23-026719
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230523
FILED AS OF DATE: 20230525
DATE AS OF CHANGE: 20230525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Strobeck Matthew
CENTRAL INDEX KEY: 0001377832
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39659
FILM NUMBER: 23962374
MAIL ADDRESS:
STREET 1: C/O METABOLIX, INC.
STREET 2: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODESIX INC
CENTRAL INDEX KEY: 0001439725
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 203986492
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 303-417-0500
MAIL ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
form4.xml
X0407
4
2023-05-23
0001439725
BIODESIX INC
BDSX
0001377832
Strobeck Matthew
2970 WILDERNESS PLACE
SUITE 100
BOULDER
CO
80301
true
false
Restricted Stock Units
2023-05-23
4
A
0
34647
0
A
Common Stock
34647
34647
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
/s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck
2023-05-25